Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics

Serum levels of free and total insulin as well as total C-peptide immunoreactivity (C-peptide and proinsulin) and C-peptide were measured in insulin-treated diabetics with circulating insulin antibodies by the addition of polyethylene glycol (PEG) before and after acidification. PEG resulted in complete precipitation of insulin antibodies from serum and made it possible to measure free insulin in the supernatant. Incubation of serum at 37δ C. for two hours before addition of PEG resulted in values for free insulin that probably resembled the in-vivo levels most closely. The same method could also be used to remove proinsulin bound to circulating insulin antibodies and permitted the measurement of C-peptide in the supernatant. Clinical studies using this approach indicate that combined measurements of serum free and total insulin and C-peptide provide information that is helpful in understanding the contribution of endogenous and exogenous insulin to the course and metabolic control of insulin-requiring diabetic patients.

[1]  D. Steiner,et al.  Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity. , 1973, The New England journal of medicine.

[2]  R. Chance,et al.  Immunogenicity of Insulin , 1972, Diabetes.

[3]  J. Cresto,et al.  Plasma Proinsulin-Like Material in Insulin Treated Diabetics , 1974, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[4]  D. Steiner,et al.  Secretion of Proinsulin C-Peptide by Pancreatic β Cells and its Circulation in Blood , 1969, Nature.

[5]  L. Miller,et al.  The Prevalence of Proinsulin-Specific Antibodies in Diabetic Patients , 1973, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[6]  V. Herbert,et al.  Coated charcoal immunoassay of insulin. , 1965, The Journal of clinical endocrinology and metabolism.

[7]  H. Kuzuya,et al.  Circulating serum C-peptide. A brief review of diagnostic implications. , 1976, New England Journal of Medicine.

[8]  K. Mashimo,et al.  A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated Patients , 1973, Diabetes.

[9]  A. Lazarow,et al.  Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats , 1963, Diabetes.

[10]  O. Andersen.  Antibodies to proinsulin in diabetic patients treated with porcine insulin preparations. , 1973, Acta endocrinologica.

[11]  L. Miller,et al.  Proinsulin-Specific Antibodies in Human Sera , 1973, Diabetes.

[12]  J. Brange,et al.  Clinical Aspects of Insulin–Antigenicity , 1972, Diabetes.

[13]  L. Heding.  Determination of Free and Antibody-Bound Insulin in Insulin Treated Diabetic Patients , 1969, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[14]  D. Steiner,et al.  Identification of proinsulin and C-peptide in human serum by a specific immunoassay. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Toyota,et al.  Extraction of plasma insulin in radioimmunoassay for removal of nonspecific inhibitor and of circulating insulin antibody. , 1970, The Tohoku journal of experimental medicine.

[16]  D. Steiner,et al.  Circulating C-peptide Immunoreactivity: Studies in Normals and Diabetic Patients , 1972, Diabetes.